Pneumococcal polysaccharide revaccination: immunoglobulin G seroconversion, persistence, and safety in frail, chronically ill older subjects

Article Abstract:

A prospective sudy has been carried out in six s killed nursing facilities in a metropolitan area to determine the one-month postpneumococcal polysacchar ide-revaccination immunoglobulin G (IgG) antibody response, its persistence at one year, and tolerability of revaccination in frail, chronically ill older residents. Re sults show that in this group revaccination with 23-valent postpneumococcal polysaccharide vaccine at least five years after primary vaccination is associated with a significant, though brief, immunological response for most serotypes tested.

All Other Miscellaneous Ambulatory Health Care Services, Vaccination & Immunization, Care and treatment, Usage, Physiological aspects, Pneumococcal vaccine, Pneumococcal vaccines, Vaccination, Immunoglobulin G, Nursing home patients, Chronically ill, Streptococcus pneumoniae, Pneumonia, Pneumococcal, Pneumococcal pneumonia

---

Differences in mortality of black and white patients enrolled in the Program of All-Inclusive Care for the Elderly

Article Abstract:

A longitudinal cohort stu dy into d ifferences in mortality of black and white patients enrolled in the P rogram of A ll-I nclusive C are for the E lderly (PACE) has been carried out. It was found that a system providing access to and coordination of comprehensieve medical and long-term care services for frail older people, black patients have a lower mortality rate than white patients. The survival advantage emerges about one year after PACE enrollment and may be related to the comprehensive access and coordination of services provided by the PACE program.

Health Care and Social Assistance, Management dynamics, SOCIAL SERVICES, Administration of Public Health Programs, Health Care Services, Medical & Health Services, Community Services, Community Food and Housing, and Emergency and Other Relief Services, Management, Mortality, Medical care, Demographic aspects, Death, Company business management, Whites, Long-term care of the sick, Long term care, Blacks, Community service, African American aged, African American elderly, Medical care (Private)

---

Gastroinstestinal disease control after histamine2-receptor antagonist dose modification for renal impairment in frail chronically ill elderly patients

Article Abstract:

Research into the effects of lowering the dosage of histamine H2 antagonists in response to reduced renal function does not increase gastrointestinal symptoms in frail elderly patients.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Geriatric Research, Drug therapy, Gastrointestinal diseases, Renal manifestations of general diseases, Renal manifestations, Histamine H2 antagonists

Similar abstracts:

• Abstracts: Delirium symptoms in post-acute care: prevalent, persistent, and associated with poor functional recovery. The protective effect of social engagement on mortality in long-term care
• Abstracts: Age deficits in retrieval: the fan effect. Investigations of inhibition and interference in younger and older adults
• Abstracts: The yield, reliability, and validity of a postal survey for screening community-dwelling older people. Depression in older patients admitted for postacute nursing home rehabilitation
• Abstracts: Effect of end-stage renal disease on the quality of life of older patients. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the modification of diet in renal disease formula an improvement?
• Abstracts: Physicians vary in approaches to the clinical management of delirium. Psychotropic prescription use by community-dwelling elderly in the United States

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.